MDbio_Logo.png
MDbio Starts Clinical Trials for Pharmaceutical-Grade Products That Target Sleeplessness, Stress and Pain
July 22, 2022 09:00 ET | MDbio Wellness
Los Angeles, July 22, 2022 (GLOBE NEWSWIRE) -- Today, MDbio, in conjunction with their research partners at Radicle Science, are announcing the start of three separate clinical trial studies which...
Healthy Directions Instaflex Provides Pain Relief During the Summer Heat
July 21, 2022 08:14 ET | Healthy Directions
BETHESDA, Md., July 21, 2022 (GLOBE NEWSWIRE) -- The summer, often synonymous with heat waves and humidity, can take a toll on anyone. However, for pain sufferers, especially those people dealing...
MDbio_Logo.png
MDbio Start Clinical Trials for Pharmaceutical-Grade Products That Target Sleeplessness, Anxiety and Pain; Expected Retail From 2023
July 14, 2022 09:00 ET | MDbio Wellness
Los Angeles, CA, July 14, 2022 (GLOBE NEWSWIRE) -- MDbio are a leading plant-based, wellness solution who provide safe, pharmaceutical-grade products and medicines. Founded by four medical doctors...
CenExel Acquires Apex Innovative Sciences
June 16, 2022 14:02 ET | CenExel Clinical Research
Salt Lake City, Utah, June 16, 2022 (GLOBE NEWSWIRE) -- CenExel announces the acquisition of Apex Innovative Sciences, parent company of Collaborative Neuroscience Research (CNS) and Hassman...
Micro-Leads Receives FDA IDE Approval for 60-Electrode Spinal Cord Stimulator System
May 21, 2022 15:46 ET | Micro-Leads Inc.
SOMERVILLE, Mass., May 21, 2022 (GLOBE NEWSWIRE) -- Micro-Leads Inc, a medical device technology company today announced FDA Investigational Device Exemption (IDE) approval for its high-definition...
180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren’s Disease Study Results in The Lancet Rheumatology
April 29, 2022 18:32 ET | 180 Life Sciences Corp.
The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in nodule size at multiple time points including 12 monthsThe treatment arm...
Facts & Factors.jpg
Global Pain Management Therapeutics Market Size & Share to Grow at 4.8% CAGR by 2026 and Reach USD 90,501.8 Million Mark: Says Facts & Factors
January 31, 2022 10:03 ET | Facts & Factors
LONDON, United Kingdom, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Pain Management Therapeutics Market By Drug Class (Anesthetics,...
IVORY BLUE Delivers a Gorgeous New Single
December 14, 2021 10:00 ET | IVORY BLUE, musician
KANSAS CITY, Mo., Dec. 14, 2021 (GLOBE NEWSWIRE) -- A free-spirited musician with a penchant for crafting tender, often haunting alt-rock anthems, IVORY BLUE has become one of the most expressive...
Sky Wellness Expands with Collection of CBD Relief and Pain Support
December 08, 2021 09:32 ET | Sky Wellness
PHOENIX, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Sky Wellness – a leading challenger brand in the CBD consumer goods industry – expands its collection of personal wellness products with a range dedicated...
ACGME Releases Recommendations and Resources on Preparing Residents and Fellows to Manage Pain and Substance Use Disorder
October 18, 2021 15:47 ET | Accreditation Council for Graduate Medical Education
Chicago, IL, Oct. 18, 2021 (GLOBE NEWSWIRE) -- The ACGME is pleased to present new recommendations, findings, and resources from the GME Stakeholder Congress on Preparing Residents and Fellows to...